Sourcing & External Supply | Lensource®

Sourcing and external

Contract Services Providers play a key role in the success of a drug development and manufacturing program. Hence the need to develop the right sourcing methodologies for Biotech and Pharma companies.

From Drug Discovery & Hit Generation to Clinical & Commercial Supply, efficient sourcing processes enable sponsors to select optimal economical, technological and value-creating solutions across the entire value chain.

Leveraging Lensource®, our proprietary sourcing solution, we enhance our clients' search for contract services partners. So they can advance their programs smoothly, fast and cost-effectively.

HUMAN AND MACHINE INTELLIGENCE COMBINED TO IDENTIFY, ASSESS AND SELECT OUTSOURCING PARTNERS.

Lensource® is a proprietary process that combines our people's biopharma outsourcing expertise with advanced AI technologies—to provide sponsors with actionable insights at a faster pace and deeper level.

100+ CRO, CDMO, CMO and CTS sourcing projects handled for Biotech and Pharma companies each year

2000+ Contract Service Providers (CSP) monitored daily via Lensource®

500Mn industry data collected, processed and analysed each year

Full Coverage of drug R&D and manufacturing value chain, CSP typologies and drug modalities

case studies Sourcing and external

TRUSTED BY 500+ BIOPHARMA COMPANIES

The Lensource® sourcing process has been trusted by over 500 Biotech & Pharma clients worldwide since 1993.

case studies Sourcing and external

99% EXHAUSTIVENESS

Missing the right partner can cost millions, so we leave no stones unturned. Lensource® maps all Contract Services options at a global scale with unmatched exhaustiveness.

case studies Sourcing and external

YOUR IDEAL PARTNER, IN 8 WEEKS

It takes 6 to 9 months for sponsors to run a sourcing process internally. Full Lensource process only takes 2—so our clients can maximize savings, efficiency and success.

A FLEXIBLE 3-STEP SOURCING PROCESS. TAILORED TO EACH PROJECT'S UNIQUE REQUIREMENTS.

Divided into 3 independent phases, Lensource® is designed to integrate each client's unique requirements and provide them with an optimal, fact-based, decision-making dashboard.

Phase I - Market Scanning

360° screening & identification based on client's primary search criteria, offering a complete view of all the potential partners available.

Phase II - Capabilities Assessment | RFI

Thorough technical capabilities assessment and CDA process management—leading to the generation of our Lensource® matrix, developed for optimal technical data collection, standardization and comparability.

Phase III - Quotations Assessment | RFQ

Proposals and Quotations gathering and analysis—leading to the generation of our Lensource® matrix, developed for optimal pricing collection, standardization and comparability.

BETTER SOURCING PROCESSES, BETTER PARTNERS, BETTER OUTCOMES.

Whether they are innovative start-up Biotech or top 10 Big Pharma companies, Lensource® solves most sourcing challenges our clients are facing. Ultimately allowing them create value all along their drug development or manufacturing programs

Benefits for Small Biotech and Pharma

  • Cut timelines
  • Focus on core & value-adding activities
  • Maximize clinical success
  • Control budget & cash burning rate
  • Boost a program attractiveness towards investors

Benefits for larger Biopharmaceutical companies

  • Improve daily third party management
  • Access innovative technologies
  • Access new territories
  • Optimize COGS
  • Minimize financial risks
  • Secure supply chain